Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9295713
APP PUB NO 20120071413A1
SERIAL NO

13233916

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF IOWA RESEARCH FOUNDATION200 S CAPITOL STREET 2660 UNIVERSITY CAPITOL CENTRE IOWA CITY IA 52242

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Marsh, Henry C Reading, US 10 144
Smith, Richard J H Iowa City, US 3 2
Zhang, Yuzhou Coralville, US 15 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00